Functional impact of different muscle localization techniques for Botulinum neurotoxin A injections in clinical routine management of post-stroke spasticity

References

• Dietz V, Sinkjaer T. Spastic movement disorder: impaired reflex function and altered muscle mechanics. Lancet Neurology 2007;6:725–733.
   PubMed Web of Science ®Google Scholar
• Foley N, Pereira S, Salter K, Fernandez MM, Speechley M, Sequeira K, Miller T, Teasell R. Treatment with botulinum toxin improves upper-extremity function post stroke: a systematic review and meta-analysis. Archives of Physical Medicine and Rehabilitation 2013;94:977–989.
   PubMed Web of Science ®Google Scholar
• Simpson DM, Alexander DN, O’Brien CF, Tagliati M, Aswad AS, Leon JM, Gibson J, Mordaunt JM, Monaghan EP. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology 1996;46:1306–1310.
   PubMed Web of Science ®Google Scholar
• Simpson DM, Gracies JM, Graham HK, Miyasaki JM, Nauman M, Russman B, Simpson LL, So Y. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008;70:1691–1698.
   Google Scholar
• Bakheit AM, Thilmann AF, Ward AB, Poewe W, Wissel J, Muller J, Benecke R, Collin C, Muller F, Ward CD, et al. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke. Stroke 2000;31:2402–2406.
   PubMed Web of Science ®Google Scholar
• Bakheit AM, Pittock S, Moore AP, Wurker M, Otto S, Erbguth F, Coxon L. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke. European Journal of Neurology 2001;8:559–565.
   PubMed Web of Science ®Google Scholar
• Brashear A, Gordon MF, Elovic E, Kassicieh VD, Marciniak C, Do M, Lee CH, Jenkins S, Turkel C. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. New England Journal of Medicine 2002;347:395–400.
   PubMed Web of Science ®Google Scholar
• Kanovsky P, Slawek J, Denes Z, Platz T, Sassin I, Comes G, Grafe S. Efficacy and safety of botulinum neurotoxin NT 201 in poststroke upper limb spasticity. Clinical Neuropharmacology 2009;32:259–265.
   PubMed Web of Science ®Google Scholar
• Brashear A, McAfee AL, Kuhn ER, Fyffe J. Botulinum toxin type B in upper-limb poststroke spasticity: a double-blind, placebo-controlled trial. Archives of Physical Medicine and Rehabilitation 2004;85:705–709.
   PubMed Web of Science ®Google Scholar
• Henzel MK, Munin MC, Niyonkuru C, Skidmore ER, Weber DJ, Zafonte RD. Comparison of surface and ultrasound localization to identify forearm flexor muscles for botulinum toxin injections. Physical Medicine and Rehabilitation 2010;2:642–646.
   Google Scholar
• Kwon JY, Hwang JH, Kim JS. Botulinum toxin a injection into calf muscles for treatment of spastic equinus in cerebral palsy: a controlled trial comparing sonography and electric stimulation-guided injection techniques: a preliminary report. American Journal of Physical Medicine & Rehabilitation 2010;89:279–286.
   PubMed Web of Science ®Google Scholar
• Lim EC, Quek AM, Seet RC. Accurate targeting of botulinum toxin injections: how to and why. Parkinsonism and Related Disorders 2011;17(Suppl 1):S34–39.
   PubMedGoogle Scholar
• Picelli A, Bonetti P, Fontana C, Barausse M, Dambruoso F, Gajofatto F, Tamburin S, Girardi P, Gimigliano R, Smania N. Accuracy of botulinum toxin type A injection into the gastrocnemius muscle of adults with spastic equinus: manual needle placement and electrical stimulation guidance compared using ultrasonography. Journal of Rehabilitation Medicine 2012;44:450–452.
   PubMed Web of Science ®Google Scholar
• Picelli A, Lobba D, Midiri A, Prandi P, Melotti C, Baldessarelli S, Smania N. Botulinum toxin injection into the forearm muscles for wrist and fingers spastic overactivity in adults with chronic stroke: a randomized controlled trial comparing three injection techniques. Clinical Rehabilitation 2014;28:232–242.
   PubMed Web of Science ®Google Scholar
• Picelli A, Tamburin S, Bonetti P, Fontana C, Barausse M, Dambruoso F, Gajofatto F, Santilli V, Smania N. Botulinum toxin type A injection into the gastrocnemius muscle for spastic equinus in adults with stroke: a randomized controlled trial comparing manual needle placement, electrical stimulation and ultrasonography-guided injection techniques. American Journal of Physical Medicine & Rehabilitation 2012;91:957–964.
   PubMed Web of Science ®Google Scholar
• Walter U, Dressler D. Ultrasound-guided botulinum toxin injections in neurology: technique, indications and future perspectives. Expert Review of Neurotherapeutics 2014;14:923–936.
   PubMed Web of Science ®Google Scholar
• Willenborg MJ, Shilt JS, Smith BP, Estrada RL, Castle JA, Koman LA. Technique for iliopsoas ultrasound-guided active electromyography-directed botulinum a toxin injection in cerebral palsy. Journal of Pediatric Orthopaedics 2002;22:165–168.
   PubMed Web of Science ®Google Scholar
• Wissel J, Ward AB, Erztgaard P, Bensmail D, Hecht MJ, Lejeune TM, Schnider P, Altavista MC, Cavazza S, Deltombe T, et al. European consensus table on the use of botulinum toxin type A in adult spasticity. Journal of Rehabilitation Medicine 2009;41:13–25.
   PubMed Web of Science ®Google Scholar
• Picelli A, Roncari L, Baldessarelli S, Berto G, Lobba D, Santamato A, Fiore P, Smania N. Accuracy of botulinum toxin type A injection into the forearm muscles of chronic stroke patients with spastic flexed wrist and clenched fist: manual needle placement evaluated using ultrasonography. Journal of Rehabilitation Medicine 2014;46:1042–1045.
   PubMed Web of Science ®Google Scholar
• Santamato A, Micello MF, Panza F, Fortunato F, Baricich A, Cisari C, Pilotto A, Logroscino G, Fiore P, Ranieri M. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques. Journal of Neurological Sciences 2014;347:39–43.
   PubMed Web of Science ®Google Scholar
• Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Physical Therapy 1987;67:206–207.
   PubMed Web of Science ®Google Scholar
• Collin C, Wade DT, Davies S, Horne V. The Barthel ADL Index: a reliability study. International Disability Studies 1988;10:61–63.
   PubMedGoogle Scholar
• Francis HP, Wade DT, Turner-Stokes L, Kingswell RS, Dott CS, Coxon EA. Does reducing spasticity translate into functional benefit? An exploratory meta-analysis. Journal of Neurololgy, Neurosurgery & Psychiatry 2004;75:1547–1551.
   PubMed Web of Science ®Google Scholar
• Wade DT, Collin C. The Barthel ADL Index: a standard measure of physical disability? International Disability Studies 1988;10:64–67.
   PubMedGoogle Scholar
• Greiner W, Weijnen T, Nieuwenhuizen M, Oppe S, Badia X, Busschbach J, Buxton M, Dolan P, Kind P, Krabbe P, et al. A single European currency for EQ-5D health states. Results from a six-country study. The European Journal of Health Economics 2003;4:222–231.
   PubMedGoogle Scholar
• Jost W. Bildatlas der Botulinumtoxin-Injektion: Dosierung, Lokalisation, Anwendung. Marburg: KVM; 2009.
   Google Scholar
• Hustedt U. Botulinumtoxin bei spastischen Bewegungsstörungen-Ultraschallgestützte Technik und Anwendung. Marburg: KVM Verlag; 2011.
   Google Scholar
• Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods 2007;39:175–191.
   PubMed Web of Science ®Google Scholar
• Elovic EP, Munin MC, Kanovsky P, Hanschmann A, Hiersemenzel R, Marciniak C. Randomized, placebo-controlled trial of incobotulinumtoxina for upper-limb post-stroke spasticity. Muscle & Nerve 2016;53:415–421.
   PubMed Web of Science ®Google Scholar
• Elovic EP, Brashear A, Kaelin D, Liu J, Millis SR, Barron R, Turkel C. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients. Archives of Physical Medicine & Rehabilitation 2008;89:799–806.
   PubMed Web of Science ®Google Scholar
• Elovic EP, Simone LK, Zafonte R. Outcome assessment for spasticity management in the patient with traumatic brain injury: the state of the art. The Journal of Head Trauma Rehabilitation 2004;19:155–177.
   PubMed Web of Science ®Google Scholar
• McCrory P, Turner-Stokes L, Baguley IJ, De Graaff S, Katrak P, Sandanam J, Davies L, Munns M, Hughes A. Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes. Journal of Rehabilitation Medicine 2009;41:536–544.
   PubMed Web of Science ®Google Scholar
• Bergfeldt U, Skold C, Julin P. Short Form 36 assessed health-related quality of life after focal spasticity therapy. Journal of Rehabilitation Medicine 2009;41:279–281.
   PubMed Web of Science ®Google Scholar
• Dressler D, Rychlik R, Kreimendahl F, Schnur N, Lambert-Baumann J. Long-term efficacy and safety of incobotulinumtoxinA and conventional treatment of poststroke arm spasticity: a prospective, non-interventional, open-label, parallel-group study. British Medical Journal Open 2015;5:e009358.
   PubMed Web of Science ®Google Scholar
• Brashear A, Zafonte R, Corcoran M, Galvez-Jimenez N, Gracies JM, Gordon MF, McAfee A, Ruffing K, Thompson B, Williams Met al, Inter- and intrarater reliability of the Ashworth Scale and the Disability Assessment Scale in patients with upper-limb poststroke spasticity. Archives of Physical Medicine & Rehabilitation 2002;83:1349–1354.
   Google Scholar